Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Watchlist Manager
Jiangsu Hengrui Pharmaceuticals Co Ltd Logo
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Watchlist
Price: 48.45 CNY -1.82% Market Closed
Market Cap: 307.6B CNY
Have any thoughts about
Jiangsu Hengrui Pharmaceuticals Co Ltd?
Write Note

Jiangsu Hengrui Pharmaceuticals Co Ltd
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Hengrui Pharmaceuticals Co Ltd
Total Other Income Peer Comparison

Comparables:
600196
H
3692
600436
000538
S
688506

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Other Income
-ÂĄ418.2m
CAGR 3-Years
-52%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Total Other Income
-ÂĄ13.9m
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Other Income
-ÂĄ25m
CAGR 3-Years
-77%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Other Income
-ÂĄ2.8m
CAGR 3-Years
19%
CAGR 5-Years
36%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Other Income
ÂĄ649.7k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Total Other Income?
Total Other Income
-418.2m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Hengrui Pharmaceuticals Co Ltd's Total Other Income amounts to -418.2m CNY.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Total Other Income growth rate?
Total Other Income CAGR 5Y
-28%

Over the last year, the Total Other Income growth was -171%. The average annual Total Other Income growth rates for Jiangsu Hengrui Pharmaceuticals Co Ltd have been -52% over the past three years , -28% over the past five years .

Back to Top